Avita Medical | 1811094D - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Accuray USD 124.78M 2.54M 2025-12
Celltrion KRW 9.32B 3.39B 2026-03
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 2.84M 4.19M 2025-12
Nanosonics AUD 53.78M 26.93M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pacific Edge NZD 16.75M 2.42M 2026-06
Paradigm Biopharmaceuticals AUD 2.83M 1.22M 2025-12
Pharma Mar EUR 17.12M 1.82M 2026-06
Polynovo AUD 17.04M 1.91M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Qiagen NV USD 142.33M 60K 2026-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 285.65M 9.96M 2026-03
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Telix Pharmaceuticals AUD 107.02M 13.54M 2026-06
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03